Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
BICYCLIC HETEROCYCLIC DERIVATIVE HAVING VIRAL GROWTH INHIBITORY ACTIVITY AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
Document Type and Number:
WIPO Patent Application WO/2023/042879
Kind Code:
A1
Abstract:
The present invention provides: a compound having coronavirus 3CL protease inhibitory activity or a pharmaceutically acceptable salt thereof; and a pharmaceutical composition containing same. Provided is a compound represented by formula (I) (in the formula, each of carbon atom a and carbon atom b is a carbon atom constituting ring A, ring A is a substituted aromatic carbon ring or the like, R1 is a substituted or unsubstituted aromatic heterocyclic group or the like, R2 is a substituted or unsubstituted 6-membered aromatic carbon ring group or the like, m is 1 or the like, R5a is each independently a hydrogen atom or the like, R5b is each independently a hydrogen atom or the like, n is 1 or the like, R4a is a hydrogen atom or the like, and R4b is a hydrogen atom or the like), or a pharmaceutically acceptable salt thereof.

Inventors:
TAODA YOSHIYUKI (JP)
UEHARA SHOTA (JP)
SAKO YUSUKE (JP)
HIRAI KEIICHIRO (JP)
Application Number:
PCT/JP2022/034552
Publication Date:
March 23, 2023
Filing Date:
September 15, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SHIONOGI & CO (JP)
UNIV HOKKAIDO NAT UNIV CORP (JP)
International Classes:
C07D401/04; A61K31/517; A61K31/519; A61K31/5377; A61K31/541; A61P31/12; A61P31/14; A61P43/00; C07D401/06; C07D401/14; C07D403/06; C07D403/14; C07D405/04; C07D405/14; C07D409/14; C07D413/14; C07D417/14; C07D451/04; C07D471/04; C07D471/10; C07D487/04; C07D487/08; C07D487/10; C07D491/048; C07D491/107; C07D495/04; C07D498/04; C07D498/08; C07D519/00; C07K14/165; C12N15/50
Domestic Patent References:
WO2019185117A12019-10-03
WO1994019342A11994-09-01
Foreign References:
JP2009500405A2009-01-08
JP2020519567A2020-07-02
KR20080004304A2008-01-09
JPH07504676A1995-05-25
JP2000119272A2000-04-25
Attorney, Agent or Firm:
SUGITA Ken-ichi et al. (JP)
Download PDF: